Moreover, it has been demonstrated that mutation in the NOTCH1 gene occurs in 20% of patients with ACC, leading to the aggressive form of the disease that induces bone and liver metastases, resulting in a worse survival rate than a wild-type population [42]. The gene discussed is NOTCH1; the disease is adrenal cortex carcinoma.